Solubility enhancement of poorly soluble API using cellulose derivatives. 28th April 2014 Shilpa Mistry
|
|
- Anastasia Perkins
- 6 years ago
- Views:
Transcription
1 Solubility enhancement of poorly soluble API using cellulose derivatives 28th April 2014 Shilpa Mistry
2 Class up to improve drug solubility BCS :Biopharmaceutics Classification system *1 More than 60% of candidate drug Absorption (Permiability) 90% (10-6) Class Ⅱa/ IIb Class Ⅳ Class Ⅰ Need to Improve 0.1mg/m Solubility Class Ⅲ Formulation Change (hard technique) Chemical Change (relatively easy)
3 Solid dispersion Physical mixture Solid dispersion Drug (Crystal) Drug (Molecule) Carrier (Polymer) Amount dissolved (mg/ ml) Solid Dispersion Drug (Crystal) solubility Physical mixture Time (min) Drug crystal amorphous (molecule) Solubility Low High Stability Stable Unstable (recrystallization) 3 Drug & polymer miscibility Stable in the process
4 Approach to Improve drug solubility Physical modifications -Micronization -Complexation (Surfactants, CyD, etc.) -Polymorphs -Solid dispersion (amorphous) Chemical modification -Soluble prodrugs -Salts Requirements of a good solid dispersion: Superstation release profile (3hrs), high API content, Good stability. 4
5 Solid dispersion Approach to Improve Drug Solubility First paper Sekiguch and Obi, Chem. Pharm. Bull Eutectic mixture (Sulfathiazole-Ascorbic acid, acetoamide, nicotineamide, urea ) Chiou and Riegelman, J. Pharm. Sci Solid dispersion (Griseofulvin-PEG6000) First commercial product -Sepamit Nifedipine Solid Solution by Kanebo since 1981 Few products on the market : because of stability issues manufacturing issues other opportunities for delivery of insoluble compounds 5
6 Preparation of solid dispersions Drug Polymer Solvent Spray Dry Spray dryer Spray Coating Co-precipitation Fluidized bed Core: lactose etc. Powder Capsule or Tablet Hot melt extrusion Using poor solvent Drug Polymer Powder Injection moulded tablets
7 Preparation of Solid dispersion Solvent method Spray drug-polymer solution Co-soluble process Miscible to solvent Hot Melt Extrusion Heat and shear drug-polymer mixture Co-melt process Thermal misible 7
8 Particle morphology Solid dispersion x1000 x250 x250 Spray Drying x1000 x Spray Drying (lactose) Melt Extrusion (milled)
9 Carrier substances for solid dispersion Polyvinylpyrrolidone Polyethylene glycols Cellulose derivatives -HPMC, HPC, HPMCP, HPMCAS Polyacrylates Urea Sugar 9
10 Structure Enteric coating agent (cellulose derivatives) HPMC HPMCAS : Methyl Hydroxypropyl : Acetyl hydrophobic : Succinoyl hydrophilic (anionic dissociation)
11 HPMCAS : Shin-Etsu AQOAT H OR CH 2 OR O OR H H H O H H O OR H H O H CH 2 OR H OR CAS; , listed in JPE, USP/NF R= -H, -CH 3, -COCH 3, -COCH 2 CH 2 COOH -CH 2 CH(OH)CH 3, -CH 2 CH(CH 3 )OCOCH 3, -CH 2 CH(CH 3 )OCOCH 2 CH 2 COOH Enteric coating agent Sustained release coating Multi functional substituent hydrophobic H-bonding Amorphous polymer chain network
12 Grades of HPMCAS ph dependent solubility Vitamin B 2 tablet 100 Acetyl Succinoyl (%) (%) 80 AS-LG/LF 8 15 AS-MG/MF 9 11 AS-HG/HF 12 7 G: Granular grade (HME and SDD) F: Fine grade (Aqueous & dry coating) % dissolved at 30 min AS-LF LG AS-MF MG AS-HF HG ph
13 Glass transition temperatures HPMC AQOAT (HPMCAS) HPMCP : Succinoyl : MeO or HPO : Acetyl : Phthalyl Tg: 165 C (P-606) Tg:120 C (AS-L) 130 C (AS-M) 135 C (AS-H) Tg: 145 C (HP-55)
14 Screening study Preparation API and polymer were dissolved in a mixed solvent (Ethanol:Dichloromethane = 1:1w/w) and then sprayed onto Teflon sheet and grounded. Polymers Hypromellose acetate succinate (HPMCAS: Shin-Etsu AQOAT AS-MF, Shin-Etsu Chem.) Hypromellose phthalate (HPMCP: HP-55, Shin-Etsu Chem.) Hypromellose (HPMC: Pharmacoat 606, Shin-Etsu Chem.) Polyvinylpyrrolidone (PVP: Kollidon K30, Sigma)
15 Screening study (solvent method) Nifedipine Griseofulvin Dipyridamole Carbamazepine Mw: 346 Mw: 352 Mw: 504 Mw: 236 water solubility: mg/mL water solubility: mg/mL water solubility: 0.004mg/mL water solubility: 0.224mg/mL solubility at ph6.8: mg/mL solubility at ph6.8: mg/mL solubility at ph6.8: mg/mL solubility at ph6.8: 0.163mg/mL solubility at ph1.2: solubility at ph1.2: solubility at ph1.2: solubility at ph1.2: mg/mL mg/mL >2.5mg/mL 0.192mg/mL NP GRF DIP CBZ
16 Screening study (solvent method) Dissolution test (ph6.8) Dissolved NP (μg/ml_) Dissolved DIP(mg/L) NP crystal HPMCAS HPMC HPMCP PVP Time (min) DIP crystal HPMCAS HPMC HPMCP PVP Time (min) HPMCAS solid dispersion improved drug dissolution Dissolved GRF (mg/l) Dissolved CMZ (mg/l) HPMCAS HPMC HPMCP PVP GRF crystal Time (min) Time (min) CBZ crystal HPMCAS HPMC HPMCP PVP
17 Screening study (solvent method) Inhibition effect of recrystallization of dissolved NP 100 (ph6.8), NP:carrier 1:1 Dissolved NP (μg/ml_100μg/ml) HPMCAS HPMCP HPMC PVP NP Crystalline Time (min)
18 Screening study (solvent method) Stability (Storage condition: 50 C in the closed bottle) Assay by HPLC (%) Dissolution of NP at 10min. (ph6.8) (mg/l_50mg/l) initial 18 months initial 18 months NP HPMCAS HPMC HPMCP PVP
19 Screening study (solvent method) Hygroscopicity Equilibrium moisture content (%) PVP HPMC HPMCP HPMCAS Relative humidity (%)
20 Large scale spray drying Formulation: HPMCAS-LG: Felodipine 3:1 Solvent, Acetone Preparation solution: Felodipine was dissolved in acetone and the HPMCAS was added slowly and mixed for one hour. Equipment: GEA Niro 12.5CC pilot plant Equipped with 4 pneumatic hammers, HEPA filters & Cyclone to collect the primary powder fraction. Including the controlled room
21 Process parameters Test Number Trial Temp(0C) Nozzle Solid content Pressure Feed Rate Particle Size LOD Quantity Bulk density (g/ml) Inlet Outlet (mm) (%) (bar) (kg/hr) D50 (um) (%) (kg) Lose Tap
22 Post Drying Before After Test Number Particle Size LOD Quantity Mesh size Temperature Air flow Time LOD after D50 (um) (%) (kg) (µm) ( C) (min) (%)
23 X-ray diffraction No.1 No.2 No.4 No.6 No.10 Intensity (cps) felodipine crystal θ ( )
24 14µm 26µm 49-53µm µm
25 Summary Particle size has a large effect on your release profile and need to take are that when scaling up to production. With the larger particle size the flow improves therefore can avoid granulation step. Post drying is essential to remove the residual solvents. Increasing our solid content to 12.4% gave the best results which results to shorter processing times and good yield.
26 Screening study (solvent method) XRD solid dispersion (API: carrier = 1:2) NP GRF* (GRF:carrier 1:4) Intensity (csp) PVP HPMCP HPMC HPMCAS Crystalline HPMCAS PVP HPMCP HPMC HPMCAS Crystalline DIP Intensity (cps) θ ( ) PVP HPMCP HPMC HPMCAS Crystallin CBZ Intensity (cps) θ ( ) PVP HPMCP HPMC HPMC Crystalline θ ( ) Amorphous solid dispersion θ ( ) 30 40
27 Operation window for melt extrusion HPMCAS shows the wider operation window among cellulose derivatives Tg N.D Tg/Tdecomp. ( C) Tdecomp Tg Pulp HPMC HPMCAS HPMCP PVPVA
28 Thermodynamic properties of HPMCAS DSC and TGA measurement DSC (mcal/s) Pulp HPMC HPMCAS Temp(ºC) Weight Loss (%) Glass Transition temperatures were appeared in cellulose derivatives (HPMC & HPMCAS) Thermal plasticity (HPMC & HPMCAS) Similar thermal decomposition temperature Pulp HPMC HPMCAS Temp (ºC)
29 HME- Feasibility studies Labo Scale Apparatus: MiniLab (Haarke Thermo) Sample: 5g (Drug-polymer[1:2] mixture) Condition: 170 C, 20rpm[screw] Milled after extrusion Formulation: NP/AQOAT (AS-L,M,H) 1/2 NP/KollidoneVA64 * 1/2 & 1/6 *: Kollidone VA64 (BASF; PVPVA copolymer) Evaluation Drug crystallinity Improvement of drug dissolution 29
30 Improvement of Drug Dissolution 100 Dissolved NP (mg/l_100mg/l) NP/AS-LF 1/2 NP/AS-MF 1/2 NP/AS-HF 1/2 NP/Kollidone VA64 1/2 NP/Kollidone VA64 1/6 NP/KollidoneVA64 1/2(160 ) Drug crystal (intact) NP Dissolution in ph Time (min) Improvement (sustained high drug release): HPMCAS > Kollidone VA64
31 Design of experiments- optimum process parameters Formulation: Shin-Etsu Aqoat HPMCAS-MG: Ibuprofen 2:1 Pharma 11 Thermo Scientific, Germany) Temperatures (Degrees) Torque (%) Speed(rpm) Feeder(kg/hr) Pressure(bar) Melt Temperature ( Degrees) Initial Zone 2 Zone 3 Zone 4 Zone 5 Zone 6 Zone 7 Zone 8 Die
32 Extrudates During processing the measured extruder torque was 25%. Our general recommendation is to use extrusion temperature for HPMCAS is 150ºC but in the presence of 33% ibuprofen it could be readily processed at 100ºC. Extruded pellets This suggests that ibuprofen acted as a plasticiser and allowed processing at a reduced temperature.
33 Injection moulding & Results Mini Jet (Thermo Scientific, UK)120 C of the injection piston and 30 C of the mould Pressure: 400 bar over 5 seconds and post pressure: 300 bar 2 sec
34 Hotmelt Extrusion (Pure HPMCAS, Haake MiniLab) grade lot viscosity Loss on Substituent (%) free acid (%) Total AS-MF cp Drying MeO HPO Ac Suc Succinic acid Acetic acid acid (%) Temp. ( ) roter (rpm) before HME Cleavage of Succinic Groups
35 Stability for Melt Extrusion Discussion: -Cleavage of Succinoyl Groups Free acid increase (dissolution ph shifts to higher) -Color Change (more yellowish) -Slight Reduction in Molecular weight at 200 C Possibility of interaction between API and free acid
36 Storage stability (NP solid dispersion) NP content of solid dispersion Assay by HPLC Storage period (18M) (%) Initial 40 C, 75%RH 50 C, closed bottle NP AQOAT HPMC HPMCP PVP Eudragit L In most cases, drug content remain the same level. (Stable) 36
37 Storage stability (NP solid dispersion) Equilibrium moisture content (25 C) Equilibrium moisture content (%) PVP HPMC HPMCP HPMCAS Relative humidity (%) AQOAT is lower hygroscopic. PVP is highly hygroscopic. absorb moisture recrystallize
38 AQOAT-NP solid dispersion pellet 100 Dissolution amount of NP (μg/ml) CH2Cl2 Ethanol Methanol Aceton Core beads : Nonpareil -101 Spray solution : 9% AS-M/NP (2:1) solution* *Solvent : CH2Cl2/EtOH, MeOH, Acetone Layering amount : 10% NP rotary fluidized bed granulator core 0 NP only Time (min) Solid dispersion layer 38
39 Conclusion AQOAT could be useful as carrier of solid dispersion. Benefit: Amorphous SD with small carrier ratio Great improvement of drug dissolution (enteric) Inhibition of recrystallization Good stability
40 HME Cleaner The cleaner consist of Hypromellose and water soluble plasticizer which is commonly used in pharmaceutical applications. How to use the cleaner: Samples are available in 4kg bags
41 Examples of HME Cleaner The cleaner consist of Hypromellose and water soluble plasticizer which is commonly used in pharmaceutical applications.
42 Microprecipitated Bulk Powder (MBP) Method m.p ºC Solubility Aqueous < 0.1 mg/ml Organic Solvents (mg/ml) DMSO > 50 Vemurafenib (For Melanoma) MeOH 4.57 AcCN 1.40 CH 2 Cl Acetone < 6 42 Shah et al. J. Pharm. Sci. 102 (3), 2013
43 Coprecipitation Process for Preparation of MBP HPMCAS, HPMCP, Eudragit L Vemurafenib Ionic polymer Crystalline API Drug + polymer dissolve in solvent Cold dilute acid / base Solvent removal Aqueous wash Drying 43 Shah et al. J. Pharm. Sci. 102 (3), 2013
44 Dissolution Profiles of Vemurafenib MBP with HPMCAS MBP with Eudragit L USP Apparatus 2 (b) with 0.09% HTAB 44 Shah et al. J. Pharm. Sci. 102 (3), 2013
45 Quality by Design (HPMCAS) Factors that may affect to performance Substitution level: Viscosity: Impurities: Acetyl / Succinoyl Methoxy / Hydroxypropoxy (Molecular weight) Free acetic acid Free succinic acid Residual salt (sodium acetate) Moisture 45
46 Factors that may affect to performance Acetyl / Succinoyl Methoxy / Hydroxypropoxy - Affect to API dissolution. - May affect to stability of API - Subject to hydrolysis - Recommended to set up a range - May affect to API dissolution Viscosity (Molecular weight) - May affect to API dissolution 46
47 Effect of Succinoyl / Acetyl Groups AS-LG AS-MG AS-HG Dissolved NP (mg/l) Sample C Sample B Sample A Dissolved NP (mg/l_100mg/l) Sample F Sample E Sample D Dissolved NP (mg/l_100mg/l) Sample G Sample H Sample I Time (min) Time (min) Time (min) *The original solubility of Nifedipine is 12 mg/l AS-LG AS-MG AS-HG Sample ID A B C D E F G H I Succinoyl, % Acetyl, %
48 Impurities within HPMCAS -Acetic acid / Succinic acid -Sodium acetate -Moisture - May affect stability of API. - Gradually increases during storage. (Except sodium acetate) Shin-Etsu is open to communicate customers to discuss QbD strategy such as Extreme samples, Variability Data, and Custom Specifications. 48
49 Recent approval of solid dispersion using Shin-Etsu AQOAT (HPMCAS) Approved on Mft Brand API Disease May, 2011 Vertex INCIVEK Telaprevir Hepatitis C Aug, 2011 Roche ZELBORAF Vemuratenib Melanoma Jan, 2012 Vertex KALYDECO Ivacaftor Systic Fibrosis Nov, 2013 Merck NOXAFIL TAB Posaconazole Immune deficiency
PHARMACEUTICAL TECHNOLOGY REPORT. Introduction. Methods
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-16 Page 1 of 7 Selection of Polymeric Carriers for Amorphous Solid Dispersions Yonglai Yang, Vivian Bi, Rae-Ann Covington, Thomas Dürig
More informationThe Role of Polymer Excipients in Hot Melt Extrusion A Continuous Manufacturing Process
The Role of Polymer Excipients in Hot Melt Extrusion A Continuous Manufacturing Process Nigel Langley ExcipientFest May 1, 2018 Hot-Melt Extrusion A Continuous Manufacturing Process Principle of HME 2
More informationImproving Oral Bioavailability by Solid Dispersions: An OSPHENA (Ospemifene) Case Study
Improving Oral Bioavailability by Solid Dispersions: An OSPHENA (Ospemifene) Case Study Zhengming (Jimmy) Chen, Ph.D., Shionogi Inc. zhengming.chen@shionogi.com Shionogi Global Business Locations London
More informationPHYSICAL STABILITY OF SPRAY DRIED SOLID DISPERSIONS OF AMORPHOUS TOLFENAMIC ACID AND POLYVINYLPYRROLIDONE K-30
PHYSICAL STABILITY OF SPRAY DRIED SOLID DISPERSIONS OF AMORPHOUS TOLFENAMIC ACID AND POLYVINYLPYRROLIDONE K-30 Copenhagen, Denmark Outline of Today s Presentation Introduction Spray drying method Amorphous
More informationSolid dispersions as a formulation strategy for poorly soluble compounds. G. Van den Mooter University of Leuven, Belgium
Solid dispersions as a formulation strategy for poorly soluble compounds G. Van den Mooter University of Leuven, Belgium 20 th Annual Symposium of the Finish Society of Physical Pharmacy Vithi, Finland
More informationSoluplus. Technical Information. October _090801e-01/Page 1 of 8. = Registered trademark of BASF group. Pharma Ingredients & Services
Technical Information Soluplus October 2009 03_090801e-01/Page 1 of 8 = Registered trademark of BASF group Pharma Ingredients & Services 03_090801e-01 October 2009 Page 2 of 8 Soluplus 1. Introduction
More informationUSP Hypromellose Phthalate
USP Hypromellose Phthalate HPMCP: CONTENTS PAGE 2 Preface Designation and structural formula of HPMCP Designation, Admissions to compendia, Chemical name Trade name Structural formula Physico-chemical
More informationPharma Ingredients & Services. Soluplus. Technical Information. = Registered trademark of BASF group. July 2010 Supersedes issue dated May 2010
Technical Information Soluplus July 21 Supersedes issue dated May 21 3_981e-4/Page 1 of 8 = Registered trademark of BASF group Pharma Ingredients & Services 3_981e-4 July 21 Page 2 of 8 Soluplus 1. Introduction
More informationComputation of Solubility parameters using Molecular. dynamics simulation
Appendix I Appendix I Computation of Solubility parameters using Molecular dynamics simulation Computational Methods Molecular dynamics (MD) simulations were carried out using the Accelrys Materials Studio[1]
More informationNISSO HPC for Pharmaceutical Applications
NISSO HPC for Pharmaceutical Applications Contents Introduction Features of NISSO HPC Major Application of NISSO HPC NISSO HPC Grades and Availability How to use based on Application and Features of NISSO
More informationWHITE PAPER: Amorphous Solid Dispersions-One approach to improving Bioavailability
2017 WHITE PAPER: Amorphous Solid Dispersions-One approach to improving Bioavailability Eric C Buxton Clinical Associate Professor University of Wisconsin Madison School of Pharmacy, Division of Pharmacy
More informationApproaches to the formulation of poorly soluble drugs
1 Approaches to the formulation of poorly soluble drugs R. Christian Moreton, Ph.D FinnBrit Consulting ExcipientFest 2013, April 30 May 01, 2013, Baltimore, MD 2 Disclaimer The views expressed in this
More informationModel-based Technology Selection for Bioavailability Enhancement CPHI DAVID K. LYON, PH.D. OCTOBER 25, 2017
Model-based Technology Selection for Bioavailability Enhancement CPHI DAVID K. LYON, PH.D. OCTOBER 25, 2017 Biopharmaceutical Classification System Approximately 80% of drugs in the pharmaceutical compounds
More informationMaximizing Roller Compaction Benefits with Proper Excipient Selection
A sponsored whitepaper. Maximizing Roller Compaction Benefits with Proper Excipient Selection By: Bernhard Fussnegger, Global Development and Technical Marketing, PVP/Coatings, Instant & Modified Release,
More informationReceived: ; Revised; Accepted:
International Journal of Institutional Pharmacy and Life Sciences 3(5): September-October 2013 INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES Pharmaceutical Sciences Research Article!!!
More informationResearch Article Pharmaceutical Sciences
Page185 Research Article Pharmaceutical Sciences ENHANCEMENT OF DISSOLUTION RATE OF EFAVIRENZ BY SOLID DISPERSION TECHNIQUE B. Venkateswara Reddy 1*, K.V. Ramana Murthy 2 1* Department of Pharmaceutics,
More informationThermodynamics of Pharmaceutical Systems
Biochemical and Chemical Engineering Thermodynamics of Pharmaceutical Systems Gabriele Sadowski TU Dortmund Dortmund March 4, 2014 Motivation APIs are complex molecules Most APIs are classified in class
More informationA practical computational tool to predict formulation and process variables during the development of spray-dried amorphous solid dispersions.
A practical computational tool to predict formulation and process variables during the development of spray-dried amorphous solid dispersions. Íris Duarte, José Luís Santos, João F. Pinto, Márcio Temtem
More informationInjection Moulding as a One-Stop-Production to Produce Pharmaceutical Dosage Forms
Injection Moulding as a One-Stop-Production to Produce Pharmaceutical Dosage Forms Karin Eggenreich, Simone Schrank, Gerold Koscher, Daniel Treffer, Eva Roblegg and Johannes G. Khinast K1 Competence Center
More informationPHARMACEUTICAL TECHNOLOGY REPORT. Introduction
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-036-1 (Supersedes PTR-036) Page 1 of 9 Water-Soluble Cellulose Ethers as Release Modulators for Ethylcellulose Coatings on Multiparticulates
More informationPreformulation. By: Ass. Prof. Gamal Shazly
Preformulation By: Ass. Prof. Gamal Shazly Preformulation Testing It is the investigation of the physical and the chemical properties of the drug substance alone and when combined with formulating excipients
More informationUniversity of Sulaimani College of Pharmacy Dept. of Pharmaceutics 5 th stage Second Semester
University of Sulaimani College of Pharmacy Dept. of Pharmaceutics 5 th stage Second Semester 2/26/2018 Industrial Pharmacy II, Dr. rer. nat. Rebaz Ali 1 Outlines Powder flow Introduction Factor affecting
More informationApplication Studies using the GTP at an Excipient Manufacturer s Laboratory
Application Studies using the GTP at an Excipient Manufacturer s Laboratory Dr. Andreas Sauer andreas.sauer@se-pfmd.com Gamlen User Meeting 22.02.2017 Outline Shin-Etsu excipients and application laboratory
More informationTwin-screw melt granulation of a thermally labile drug
Twin-screw melt granulation of a thermally labile drug FENG ZHANG UNIVERSITY OF TEXAS AT AUSTIN 8 TH AMERICAN DRUG DELIVERY AND FORMULATION SUMMIT SAN FRANCISCO, SEPTEMBER 10, 2018 1 Objectives Twin-screw
More informationNew and Emerging Uses of Polymeric Excipients to Overcome Drug Delivery Challenges
New and Emerging Uses of Polymeric Excipients to Overcome Drug Delivery Challenges Thomas Dürig tdurig@ashland.com 1 Critical Importance of Excipients Biopharmaceutical factors modulated by excipients
More informationPreface... iii Contents...vii Contributors...xv. 1 Introduction to Hot-Melt Extrusion, Continuous Manufacturing: Scale-up via Hot-Melt Extrusion...
Contents Preface... iii Contents...vii Contributors...xv 1 Introduction to Hot-Melt Extrusion, Continuous Manufacturing: Scale-up via Hot-Melt Extrusion... 1 1 Background... 1 1.1 Introduction... 1 1.1.1
More informationDeconvoluting Amorphous Solid Dispersion Dissolution
Deconvoluting Amorphous Solid Dispersion Dissolution Jonathan Booth Formulation Science Section AstraZeneca Macclesfield PhysChem Forum 11 Meeting Nottingham, September 21 st 2011 Whats the Problem? ~
More informationSolubility of Small-molecule Drugs into Polymer Excipients in Hot Melt Extruded Dosage Forms
ANNUAL TRANSACTIONS OF THE NORDIC RHEOLOGY SOCIETY, VOL. 22, 204 Solubility of Small-molecule Drugs into Polymer Excipients in Hot Melt Extruded Dosage Forms Johanna Aho, Magnus Edinger, Johan P. Boetker,
More informationAquaSolve. hydroxypropylmethylcellulose acetate succinate. Physical and chemical properties handbook
AquaSolve hydroxypropylmethylcellulose acetate succinate Physical and chemical properties handbook Table of Contents INTRODUCTION..................................... 4 CHEMISTRY.........................................
More informationCHAPTER 8: SOLID DOSAGE FORM COATING TECHNOLOGY NOOR MUHAMMAD SYAHRIN BIN YAHYA INTRODUCTION
CHAPTER 8: SOLID DOSAGE FORM COATING TECHNOLOGY NOOR MUHAMMAD SYAHRIN BIN YAHYA INTRODUCTION INTRODUCTION Coating technology is used extensively in the pharmaceutical industry, e.g. for the application
More informationDissolution Enhancement of Active Pharmaceutical Ingredients in Eudragit E100 by Melt Extrusion Coupled with Supercritical Carbon Dioxide
Dissolution Enhancement of Active Pharmaceutical Ingredients in Eudragit E100 by Melt Extrusion Coupled with Supercritical Carbon Dioxide Martial SAUCEAU 1, Tamás VIGH 2, Elisabeth RODIER 1, Zsombor NAGY
More informationKollicoat IR. The application of Kollicoat IR as a Zero Peroxide Binder for use in Solid Oral Dosage Forms. ExcipientFest.
Kollicoat IR The application of Kollicoat IR as a Zero Peroxide Binder for use in Solid Oral Dosage Forms ExcipientFest Nigel Langley Market Need Platforms Instant & Modified Release Solubilization Skin
More informationThe Use of Klucel Pharm Hydroxypropylcellulose to Increase the Utility of Hydroxypropyl Methylcellulose in Aqueous Film Coating
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-049-1 (Supersedes PTR-049) Page 1 of 6 The Use of Klucel Pharm Hydroxypropylcellulose to Increase the Utility of Hydroxypropyl Methylcellulose
More informationTASTE MASKING WITH COATINGS. Coating Technology 96 October 8-9, Presented by Ralph E. Pondell Corporate Secretary
96-2 TASTE MASKING WITH COATINGS Coating Technology 96 October 8-9, 1996 Presented by Ralph E. Pondell Corporate Secretary Coating Place, Inc. P.O. Box 930310 Verona, WI 53593 (608) 845-9521 When dealing
More informationGeneration of high drug loading amorphous solid dispersions by Spray Drying
IDS 2018 21st International Drying Symposium València, Spain, 11-14 September 2018 DOI: http://dx.doi.org/10.4995/ids2018.2018.7871 Generation of high drug loading amorphous solid dispersions by Spray
More informationPharma Ingredients & Services. Kollidon VA 64 Kollidon VA 64 Fine. Copovidone Ph.Eur., USP, Copolyvidone JPE. Technical Information
Technical Information June 2008 Supersedes issue dated October 2007 EMP 050602e-05/Page 1 of 16 Kollidon VA 64 Kollidon VA 64 Fine Copovidone Ph.Eur., USP, Copolyvidone JPE = Registered trademark of BASF
More informationPHARMACEUTICAL PRINCIPLES OF SOLID DOSAGE FORMS
PHARMACEUTICAL PRINCIPLES OF SOLID DOSAGE FORMS J. T. Carstensen, Ph.D. Professor of Pharmacy University of Wisconsin Madison, Wisconsin TECHNOMIC ^PUBLISHING CO.. INC J 1.ANCASTER BASET, TABLE OF CONTENTS
More informationPHARMACEUTICAL TECHNOLOGY REPORT. Introduction. Methods
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-092 Page 1 of 7 Plasticizer Compatibility and Thermal and Rheological Properties of Plasdone povidone And copovidone polymers for Hot-melt
More informationAn Updated Review on The Utilization of Various Carriers and Methods to Prepare Solid Dispersions of BCS Classified Drugs
An Updated Review on The Utilization of Various Carriers and Methods to Prepare Solid Dispersions of BCS Classified Drugs Izza Tariq* Department of Computer Science, Lahore University of Management Sciences,
More informationResearch Journal of Pharmaceutical, Biological and Chemical Sciences
Research Journal of Pharmaceutical, Biological and Chemical Sciences Improved Physicochemical Characteristics of Amorphous Drug Solid Dispersions Department of Pharmaceutics, SVCP, Hyderabad, India. A
More informationExcipient Development at NCL
New Reverse Enteric Polymer for Oral Dosage Forms Excipient Development at omplete Solution for Taste Masking Moisture Barrier Sustained Release Immediate Release Polymorphism Inhibition National hemical
More informationAmorphous drugs and drug delivery systems
Amorphous drugs and drug delivery systems Thomas Rades Faculty of Health and Medical Sciences Department of Pharmacy University of Copenhagen Universitetsparken 2 2100 København Ø DENMARK Dias 1 Outline
More informationFunctionalized Calcium Carbonate (FCC) FCC: Newly developed structured minerals as multifunctional excipients
Functionalized Calcium Carbonate (FCC) FCC: Newly developed structured minerals as multifunctional excipients ExcipientFest Americas, San Juan, PR April 29 th 2015 Dr. Carolina Diaz Quijano_ carolina.diazquijano@omya.com
More informationKollidon VA 64. Technical Information. Copovidone Ph.Eur.
Technical Information ME 080 e (939) March 2000 (MPM) Kollidon VA 64 Copovidone Ph.Eur. Register 2 = Registered trademark of BASF Aktiengesellschaft Kollidon VA 64 is a vinylpyrrolidone-vinyl acetate copolymer
More informationDrug Authentication & Preformulation Study
Drug Authentication & Preformulation Study 5.1.Drug Authentication: 5.1.1.Certificate of Analysis : Direct tabletting and BA improvements of MA by spherical crystallization tech. 86 Direct tabletting
More informationPolymorph Screening Strategies and a Concomitant Polymorph Case Study
Polymorph Screening Strategies and a Concomitant Polymorph Case Study Aniruddh Andy Singh, Ph.D. Mahmoud Mirmehrabi, Ph.D., P.Eng. Johnson Matthey Pharma Services Chemical and Crystallization Research
More informationSpray-drying Biotherapeutics
Spray-drying Biotherapeutics Richard Kaye Investigator Product Development GSK R&D APS Freeze Drying and Alternative Drying Technologies for Parenterals Burleigh Court, Loughborough 28th January 2015 Contents
More informationPharma Ingredients & Services. Kollicoat IR White. Technical Information
Technical Information Kollicoat IR White August 2008 Supersedes issue dated June 2008 EMP 040901e-10/Page 1 of 12 = Registered trademark of BASF SE Ready-to-use coating for instant-release dosage forms
More informationMelt processing of pharmaceutical compounds: future developments & learnings from the plastics industry
Melt processing of pharmaceutical compounds: future developments & learnings from the plastics industry Adrian Kelly Centre for Pharmaceutical Engineering Science, University of Bradford APS Amorphous
More informationPractical Guide to Hot-Melt Extrusion: Continuous Manufacturing and Scale-up
Practical Guide to Hot-Melt Extrusion: Continuous Manufacturing and Scale-up Editor: Mohammed Maniruzzaman (C(%SM1THERS R A P R A A Smithers Group Company Shawbury, Shrewsbury, Shropshire, SY4 4NR, United
More information7th Training School on Microencapsulation Strasbourg. Februar 2015 Textmasterformat in Mastervorlage eingeben
7th Training School on Microencapsulation Strasbourg Februar 2015 1 Dr. Anne Ettner, Glatt Pharmaceutical Services 2 Overview 1. Introduction 2. Fluid bed equipment 3. Basics of fluid bed Wurster technology
More informationPHARMACEUTICAL TECHNOLOGY REPORT. Introduction. Experimental Methods
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-81 Page 1 of 5 Hot Melt Extrusion with Klucel hydroxypropylcellulose HPC for the Controlled Release of High Doses of a Highly Soluble
More informationWorking with Amorphous API s
Working with Amorphous API s Edwin Aret Avantium Technologies BV Drug Development of Tomorrow Tuohilampi / Vihti, Finland 28-29 January 2009 Agenda Solid form selection Marketed examples Amorphous state
More informationWater in Food, Lausanne 2004
Water in Food, Lausanne 2004 Characterising the Amorphous State in a Pharmaceutical Powder Using Moisture and Organic Vapour Sorption Frank Thielmann,* Daniel Burnett,** Jürgen Adolphs,*** *Surface Measurement
More informationChapter 2 Theoretical Considerations in Developing Amorphous Solid Dispersions
Chapter 2 Theoretical Considerations in Developing Amorphous Solid Dispersions Riikka Laitinen, Petra A. Priemel, Sachin Surwase, Kirsten Graeser, Clare J. Strachan, Holger Grohganz and Thomas Rades 2.1
More informationMethyl Cellulose and Hydroxypropyl Methyl Cellulose
Ronas Chemicals Ind.Co.,Ltd. Tel/Fax:86-28-8608-2869 Email:d.chen@ronasgroup.com www.ronasgroup.com Methyl Cellulose and Hydroxypropyl Methyl Cellulose Brief Introduction: Name: Methyl Cellulose Abbreviation:
More informationHIGH PRESSURE MICRONISATION OF POLYMERS
HIGH PRESSURE MICRONISATION OF POLYMERS Željko Knez University of Maribor, Faculty of Chemistry and Chemical Engineering, Smetanova 17, SI-2000 Maribor, Slovenia Fax: +386 2 25 16 750, e-mail: zeljko.knez@uni-mb.si
More informationKollidon SR: A polyvinyl acetate based excipient for DCsustained-release
Kollidon SR: A polyvinyl acetate based excipient for DCsustained-release oral dosage forms by Dr. Bernhard Fussnegger BASF Aktiengesellschaft, Ludwigshafen Strategic Marketing Pharma Excipients Introduction
More informationPHARMACEUTICAL TECHNOLOGY REPORT. Introduction. Experimental Methods
PHARMACEUTICAL TECHNOLOGY REPORT Consumer Specialties ashland.com PTR-079 Page 1 of 5 Advantages of Hot Melt Extrusion for the Controlled Release of High Doses of Highly Soluble Actives E. Pinto, H. Yang,
More informationFORMULATION STRATEGIES FOR LOW SOLUBLE DRUGS - AN OVERVIEW. René Holm, PhD Divisional Director Biologics and Pharmaceutical Science
FORMULATION STRATEGIES FOR LOW SOLUBLE DRUGS - AN OVERVIEW René Holm, PhD Divisional Director Biologics and Pharmaceutical Science Presentation objectives Provide a general overview of the formulation
More informationThermal and Rheological Evaluation of Pharmaceutical Excipients for Hot Melt Extrusion
Thermal and Rheological Evaluation of Pharmaceutical Excipients for Hot Melt Extrusion Karen Coppens, Mark Hall, Pam Larsen, Shawn Mitchell, P. Nguyen, Mike Read, Uma Shrestha, Parvinder Walia The Dow
More informationPharma Ingredients & Services. Ludiflash. Technical Information
Technical Information Ludiflash March 2012 Supersedes issue dated August 2011 03_070805e-03/Page 1 of 10 = Registered trademark of BASF group Excipient for fast-disintegrating oral dosage forms Direct
More informationInvestigation of a Venlafaxine HCl (37.5 mg) Extended Release Formulation Using Hypromellose (HPMC) Matrices
METHOCEL Application Data Partially Pregelatinized Maize Starch Investigation of a Venlafaxine HCl (37.5 mg) Extended Release Formulation Using Hypromellose (HPMC) Matrices ABSTRACT SUMMARY The aim of
More informationHigh-Concentration Monoclonal Antibody Powder Suspension in Non-aqueous Vehicle for Subcutaneous Injection
Slide 1 High-Concentration Monoclonal Antibody Powder Suspension in Non-aqueous Vehicle for Subcutaneous Injection Mayumi Bowen Pharmaceutical Processing & Technology Development Genentech, Inc AAPS Annual
More informationMiniLab-Compounder and Reactor
MiniLab-Compounder and Reactor Georgius Isaakides, Dr. A. Frendel, J. Bouton Thermo Haake, Dieselstrasse 4, D-76771 Karlsruhe, Germany Jacques.bouton@thermorheo.com Presented on PPS-17, Montreal Abstract
More informationOn-Demand Manufacturing of Pharmaceuticals
On-Demand Manufacturing of Pharmaceuticals Innovation in continuous filtration, drying and formulation of drugs International Symposium on Continuous Manufacturing of Pharmaceuticals Salvatore Mascia Sep
More informationPHARMACEUTICAL TECHNOLOGY REPORT. Introduction. Methods. Ashland Specialty Ingredients ashland.com
PHARMACEUTICAL TECHNOLOGY REPORT Ashland Specialty ashland.com PTR-96 Page 1 of 5 Utility of Polyplasdone crospovidone as a Solubilizer Quyen Schwing, Marvin Davis, Divya Tewari, Thomas Dürig Ashland Specialty,
More informationVacuum Compression Molding as sample preparation for thermal analysis of thermoplastic materials.
Vacuum Compression Molding as sample preparation for thermal analysis of thermoplastic materials. Dr. Daniel Treffer, CEO and Founder STK Annual Meeting, May 15th 2018 Innovation in Thermal Analysis and
More informationCrystallization & Filtration
Crystallization & Filtration Purification of Salicyclic Acid and Sodium Chloride Separation processes Liquid-liquid extraction Adsorption Filtration Solid-liquid extraction (leaching) Elution chromatography
More informationAMORPHOUS SYSTEMS: CHARACTERISATION, FORMULATION AND STABILISATION. Thomas Rades
AMORPHOUS SYSTEMS: CHARACTERISATION, FORMULATION AND STABILISATION Thomas Rades More than 40 % of newly discovered drugs have little or no water solubility More the 90 % of drugs approved since 1995 have
More information(12) United States Patent
(12) United States Patent Jordan USOO6495163B1 (10) Patent No.: () Date of Patent: Dec. 17, 2002 (54) MOISTURE BARRIER FILM COATING COMPOSITION, METHOD AND COATED FORM (75) Inventor: Martin Philip Jordan,
More informationThe objective of this study was to investigate solid dispersions (SDs) of poorly water soluble drug carbamazepine (CBZ),
ORIGINAL ARTICLE Solubility and dissolution enhancement of HPMC based solid dispersions of carbamazepine by hot melt extrusion technique Sharadchandra Dagadu Javeer, Purnima Dhanraj Amin Department of
More informationDRY COATING : Techniques & Potentials
Water in Food Workshop Lausanne 2004 DRY COATING : Techniques & Potentials E. TEUNOU - E. IVANOVA - D. PONCELET Nantes Département du Génie des Procédés Alimentaire Content Who are we? Importance and Functionality
More informationMethacrylic acid ethyl acrylate copolymer (1:1) dispersion 30 per cent (e.g. Kollicoat MAE 30 DP)
Investigating the effect of partial neutralisation of the polymer on the dissolution characteristics of poly(methacrylic acid-co-ethyl acrylate) based coats Carolina Corell 1,3 ; Florian Bang 1 ; Thorsten
More informationFormulation, Development and Evaluation of delayed release capsules of Duloxetine Hydrochloride made of different Enteric Polymers
International Journal of Drug Development & Research January-March 2012 Vol. 4 Issue 1 ISSN 0975-9344 Available online http://www.ijddr.in Covered in Official Product of Elsevier, The Netherlands SJR Impact
More informationDetection and Quantification of Amorphous Content in Pharmaceutical Materials
Detection and Quantification of Amorphous Content in Pharmaceutical Materials Steven R. Aubuchon, Ph.D. TA Instruments, 109 Lukens Drive, New Castle, DE 19720, USA and Leonard C. Thomas DSC Solutions,
More information* Current monograph name valid until May 1, 2017 ** New monograph name valid as of May 1, 2012, mandatory as of May 1, 2017
Technical Information EUDRAGIT L 30 D-55 Specification and Test Methods Ph. Eur. Methacrylic Acid - Ethyl Acrylate Copolymer (1:1) Dispersion 30 Per Cent USP/NF Methacrylic Acid Copolymer Dispersion -
More informationCo-precipitation of Mefenamic Acid and Polyethylene Glycol 4000 Using the Gas Anti-Solvent (GAS) Process
440 Chiang Mai J. Sci. 2013; 40(3) Chiang Mai J. Sci. 2013; 40(3) : 440446 http://it.science.cmu.ac.th/ejournal/ Contributed Paper Coprecipitation of Mefenamic Acid and Polyethylene Glycol 4000 Using the
More informationf a c t s T C C T B Tricalcium citrate as excipient for direct compression
f a c t s T C C T B Tricalcium citrate as excipient for direct compression Direct compression has gained enormous popularity in tablet manufacturing in recent times. It is seen as the most economic process
More informationPhysical pharmacy. dr basam al zayady
Physical pharmacy Lec 5 dr basam al zayady Liquefaction of Gases: When a gas is cooled, it loses some of its kinetic energy in the form of heat, and the velocity of the molecules decreases. If pressure
More informationCH241 Experiment #1 (Weeks of September 11, 18, and 25, 2017)
CH241 Experiment #1 (Weeks of September 11, 18, and 25, 2017) SEPARATION AND RECOVERY OF ORGANIC COMPOUNDS, THIN LAYER CHROMATOGRAPHY, COLUMN CHROMATOGRAPHY, CRYSTALLIZATION, AND MELTING POINTS Overview
More informationDevelopment and characterization of ternary solid dispersion granules of poorly water soluble drugs : diflunisal and mefenamic acid
The University of Toledo The University of Toledo Digital Repository Theses and Dissertations 2011 Development and characterization of ternary solid dispersion granules of poorly water soluble drugs :
More informationHow to Identify Critical Quality Attributes and Critical Process Parameters
How to Identify Critical Quality Attributes and Critical Process Parameters Jennifer Maguire, Ph.D. Daniel Peng, Ph.D. Office of Process and Facility (OPF) OPQ/CDER/FDA FDA/PQRI 2 nd Conference North Bethesda,
More informationPreparation and Evaluation of Extended Release Pellets of Chiral Molecules of s-metoprolol Succinate by Different Technology
ORIGINAL ARTICLE Preparation and Evaluation of Extended Release Pellets of Chiral Molecules of s-metoprolol Succinate by Different Technology Dipesh V. Patel 1, Bhupendra G. Prajapati 2 1 Department of
More informationRahavard Tamin Pharmaceutical Co. (RTPC)
Rahavard Tamin Pharmaceutical Co. (RTPC) Rahavard Tamin Pharmaceutical Company adopting the latest technology in the world has succeeded in initiating optimization in the pharmaceutical industry. The monopoly
More informationDow Pharma Solutions. ETHOCEL High Productivity (HP) Polymers Safe. Fast. Efficient.
Dow Pharma Solutions ETHOCEL High Productivity (HP) Polymers Safe. Fast. Efficient. Improving Productivity Through Innovation ETHOCEL Polymers is the oldest trademarked brand available from The Dow Chemical
More information2. Crystallization. A. Background
2. Crystallization A. Background Crystallization is one of several available techniques available to purify organic compounds. Unlike other techniques, however, crystallization is specific to the purification
More informationKollidon The Original Setting new standards in stability, purity and patient safety.
Kollidon The Original Setting new standards in stability, purity and patient safety. Now with new PeroXeal packaging Bernhard Fussnegger, an enabler in excipients Pharma Ingredients & Services. Welcome
More informationThe use of surrogates for dissolution testing for Immediate Release (IR) formulations, when is it feasible?
The use of surrogates for dissolution testing for Immediate Release (IR) formulations, when is it feasible? Limin Zhang (Bristol-Myers Squibb Company) Andre Hermans (Merck & Co., Inc.) 2017 M-CERSI Workshop
More informationMETHOCEL. TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow
METHOCEL Cellulose Ethers A product that can do it all TM Trademark of The Dow Chemical Company ( Dow ) or an affiliated company of Dow The possibilities are endless Pharmaceutical companies are continuously
More informationETHOCEL High Productivity (HP) Polymers Safe. Fast. Efficient.
Dow Pharma Solutions ETHOCEL High Productivity (HP) Polymers Safe. Fast. Efficient. This document is valid at the time of distribution. Distributed 22-?-218 (UTC) Improving Productivity Through Innovation
More informationEnhancement of dissolution rate of poorly-soluble active ingredients by Supercritical Fluid processes. Part II: Preparation of composite particles
Enhancement of dissolution rate of poorly-soluble active ingredients by Supercritical Fluid processes. Part II: Preparation of composite particles Formulation processes: Michel PERRUT, Jennifer JUNG, Fabrice
More informationETHOCEL High Productivity (HP) Polymers Safe. Fast. Efficient.
Dow Pharma Solutions ETHOCEL High Productivity (HP) Polymers Safe. Fast. Efficient. This document is valid at the time of distribution. Distributed 7-Oct-218 (UTC) Improving Productivity Through Innovation
More informationAspects of Screw Design for Wet Granulation Extrusion
Aspects of Screw Design for Wet Granulation Extrusion J. Sun, M. R. Thompson Department of Chemical Engineering, McMaster University, Hamilton, Ontario, Canada ABSTRACT This paper discusses our preliminary
More informationEnhancement of Dissolution Rate of Ramipril Tablets by Solid Dispersion Technique
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS) e-issn:2278-3008, p-issn:2319-7676. Volume 12, Issue 3 Ver. I (May. - June.2017), PP 55-62 www.iosrjournals.org Enhancement of Dissolution Rate
More informationAnanda Kumar CH. et al. / International Journal of Biological & Pharmaceutical Research. 2012; 3(7):
904 e- ISSN 0976-3651 Print ISSN 2229-7480 International Journal of Biological & Pharmaceutical Research Journal homepage: www.ijbpr.com IJBPR DEVELOPMENT OF ITRACONAZOLE IMMEDIATE RELEASE PELLETS BY USING
More informationPHASE EQUILIBRIA AND THE PHASE RULE
PHASE EQUILIBRIA AND THE PHASE RULE Introduction The three primary phases of matter are often defined individually under different conditions. In practice we encounter states of matter in coexistence.
More information2. Crystallization. A. Background
2. Crystallization A. Background Crystallization is one of several available techniques available to purify organic compounds. Unlike other techniques, however, crystallization is specific to the purification
More informationThermal Analysis. Dr. Lidia Tajber School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin
Thermal Analysis Dr. Lidia Tajber School of Pharmacy and Pharmaceutical Sciences, Trinity College Dublin Characterisation for Pharma Active pharmaceutical ingredients (API, drugs) Organic molecules, peptides,
More informationAssistant Lecturer. Sahar Mohammed Shakir Assistant Lecturer. Abdul Hafeedh Hameed Assistant Lecturer. Ali Basim
Assistant Lecturer Sahar Mohammed Shakir Assistant Lecturer Abdul Hafeedh Hameed Assistant Lecturer Ali Basim Solid organic cpd.s when isolated from organic reaction are impure; they are contaminated with
More information